Novo awaits green light for diabetes drug (vol 27, pg 682, 2009)

被引:0
|
作者
May, Mike
机构
关键词
D O I
10.1038/nbt1009-957c
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Nat. Biotechnol. 27, 682–685 (2009); published online 7 August 2009; corrected after print 8 October 2009 In the version of this article initially published, GLP-1 was incorrectly described as “glucose-lowering peptide-1”; the correct definition is “glucagon-like peptide-1.” The article also stated incorrectly that Amylin and Lilly “filed a new drug application for this drug in July.
引用
下载
收藏
页码:957 / 957
页数:1
相关论文
共 50 条